Key result
Agoraphobia in women was associated with a higher prevalence of mitral valve prolapse syndrome compared to controls (44.0% vs 8.7%).
Why the study?
Is mitral valve prolapse syndrome more prevalent in agoraphobic women compared to controls?
Case-Control (n=48)
Is mitral valve prolapse syndrome more prevalent in agoraphobic women compared to controls?
Absolute Event Rate: 44% vs 8.7%
A significant proportion of agoraphobic women have evidence of mitral valve prolapse syndrome compared to healthy controls.
Does not support MVP screening in agoraphobia; small observational study leaves association hypothesis-generating.
Twenty-five agoraphobic women were compared with 23 controls for the presence of mitral valve prolapse syndrome (MVP). All subjects underwent cardiac examination, electrocardiography, phonocardiography, and echocardiography. Eleven of the agoraphobic patients had MVP; 5 had echo findings alone, 3 had both auscultory and echo findings, and 3 had auscultory findings alone. Two controls had evidence of MVP, both with echo findings alone. Echo chamber size and wall motion were similar in both groups. One patient had inferior T wave changes on ECG while all controls had normal tracings. The authors conclude that a significant number of agoraphobic patients have MVP and discuss the thoretical and clinical implications of this association.
No takes yet. Share an insight, caveat, or question.
Kantor et al. (1980) conducted a case-control in Agoraphobia (n=48). Agoraphobia vs. Controls was evaluated on Presence of mitral valve prolapse syndrome (MVP). Agoraphobia in women was associated with a higher prevalence of mitral valve prolapse syndrome compared to controls (44.0% vs 8.7%).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: